# OnCo record triumvira-immunologics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/triumvira-immunologics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "triumvira-immunologics" ;
  schema:name "Triumvira Immunologics"@en ;
  schema:alternateName "Triumvira Immunologics, Inc."@en ;
  schema:description "Triumvira Immunologics is a Texas and Ontario cell-therapy company whose T-cell antigen coupler (TAC) engages the natural T-cell receptor rather than a CAR; TAC01-CLDN18.2 targets stomach and pancreatic cancers."@en ;
  schema:url <https://onco.cc/companies/triumvira-immunologics/>, <https://www.triumvira.com/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://www.triumvira.com/> ;
  onco:tag "drug-maker" ;
  schema:addressCountry "US" ;
  onco:drugs <https://onco.cc/drugs/tac01-cldn18-2/> .